CORBUS PHARMACEUTICALS HLDGS - COM (CRBP)

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
23,559,925
Share change
+2,488,640
Total reported value
$144,228,866
Put/Call ratio
365%
Price per share
$6.10
Number of holders
75
Value change
+$12,279,533
Number of buys
43
Number of sells
30

Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q1 2018

As of 31 Mar 2018, CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,559,925 shares. The largest 10 holders included FMR LLC, Knoll Capital Management, LP, BlackRock Inc., ETF MANAGERS GROUP, LLC, VANGUARD GROUP INC, IFP Advisors, Inc, STATE STREET CORP, BAKER BROS. ADVISORS LP, MORGAN STANLEY, and NORTHERN TRUST CORP. This page lists 75 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.